Pharvaris NV (FRA:9EN)
€ 17 -0.7 (-3.95%) Market Cap: 937.51 Mil Enterprise Value: 632.43 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Pharvaris NV at Needham Healthcare Conference (Virtual) Transcript

Apr 11, 2022 / 12:45PM GMT
Release Date Price: €16.6 (-1.19%)
Serge Belanger
Needham & Company, LLC - Analyst

Hi, good morning. Happy Monday. Welcome to our Needham's 21st Annual Healthcare Conference. I'm Serge Belanger, one of the healthcare analysts at Needham. And this morning, to kick off our conference, happy to welcome the Pharvaris team. We have Berndt Modig, the President and CEO; as well as Morgan Conn, the Chief Business Officer of the company. And they'll tell us a little bit more about Pharvaris. And for those listening in, there is a Q&A portal where you can submit your questions. We'll do Q&A after the presentation. So, gentlemen, the floor is yours.

Berndt Modig
Pharvaris N.V. - CEO, Director

Great. Thanks, Serge. Hi, everyone. Good morning and thanks for joining us here today. For the next 30 minutes, we'll talk about Pharvaris, and hope we'll have some time for Q&A. So on the next slide then, here is that overview, and then we'll talk about some of these things in more detail in the deck. And by the way, the presentation that we're going to go through is also available on our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot